Search hospitals > Michigan > Warren
Saint John Macomb-Oakland Hospital
Claim this profileWarren, Michigan 48093
Global Leader in Thyroid Cancer
Global Leader in Lung Cancer
Conducts research for Relapse
Conducts research for Breast Cancer
Conducts research for Stomach Cancer
318 reported clinical trials
7 medical researchers
Summary
Saint John Macomb-Oakland Hospital is a medical facility located in Warren, Michigan. This center is recognized for care of Thyroid Cancer, Lung Cancer, Relapse, Breast Cancer, Stomach Cancer and other specialties. Saint John Macomb-Oakland Hospital is involved with conducting 318 clinical trials across 444 conditions. There are 7 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.Area of expertise
1Thyroid Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Tareq Al BaghdadiGenesys Hurley Cancer Institute8 years of reported clinical research
Expert in Thyroid Cancer
Expert in Cancer
73 reported clinical trials
130 drugs studied
Christopher M. Reynolds, MDSaint Joseph Mercy Hospital2 years of reported clinical research
Expert in Thyroid Cancer
Expert in Lung Cancer
51 reported clinical trials
104 drugs studied
Philip J. StellaSaint Joseph Mercy Hospital5 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
38 reported clinical trials
89 drugs studied
Elie G. DibGenesys Hurley Cancer Institute6 years of reported clinical research
Expert in Thyroid Cancer
Studies Multiple Myeloma
38 reported clinical trials
105 drugs studied
Clinical Trials running at Saint John Macomb-Oakland Hospital
Breast Cancer
Bladder Cancer
Skin Cancer
Lung Cancer
Breast cancer
Non-Small Cell Lung Cancer
Multiple Myeloma
Bladder Carcinoma
Pancreatic Cancer
Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Saint John Macomb-Oakland Hospital?
Saint John Macomb-Oakland Hospital is a medical facility located in Warren, Michigan. This center is recognized for care of Thyroid Cancer, Lung Cancer, Relapse, Breast Cancer, Stomach Cancer and other specialties. Saint John Macomb-Oakland Hospital is involved with conducting 318 clinical trials across 444 conditions. There are 7 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.
Where is Saint John Macomb-Oakland Hospital located?
**Ascension Macomb-Oakland Hospital Locations:**
- **Warren Campus:** 11800 Twelve Mile Rd, Warren, MI 48093
- **Madison Heights Campus:** 27351 Dequindre Rd, Madison Heights, MI 48071
Who should I call to ask about financial aid or insurance network?
For Saint John Macomb-Oakland Hospital's financial assistance and insurance inquiries, please use the following contact numbers:
- **Financial Assistance:** 800-494-5797
- **Billing and Payment:**
- Ascension St. John: 877-809-6191
- Ascension Providence: 800-878-2455
- Ascension River District: 810-329-5318
- Ascension Macomb/Oakland: 877-809-6191
For specific questions or concerns, please contact the hospital directly.
What insurance does Saint John Macomb-Oakland Hospital accept?
Ascension Macomb-Oakland Hospital, also known as Saint John Macomb-Oakland Hospital, accepts various insurance plans, including Priority Health, Blue Cross Blue Shield, AARP (UnitedHealthcare) Medicare, Health Alliance Plan (HAP), McLaren Health Plan, and MediGold/Trinity Health Plan of MI. These plans cover a wide range of services, from preventive care to specialized treatments. It is important to confirm benefit coverage with your insurance company before scheduling an appointment and consult your health plan for any referral or authorization requirements.
What awards or recognition has Saint John Macomb-Oakland Hospital received?
Ascension Macomb-Oakland Hospital, located in Warren, Michigan, is an accredited teaching hospital featuring more than 20 training programs and hosting approximately 240 residents and fellows. It has been recognized for its significant contributions to improving outcomes for Americans suffering from heart disease and stroke.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.